| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
347 |
309 |
$5K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
169 |
153 |
$2K |
| 80053 |
Comprehensive metabolic panel |
945 |
781 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
433 |
302 |
$769.92 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
39 |
26 |
$450.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
30 |
27 |
$383.70 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,021 |
851 |
$382.03 |
| 71046 |
Radiologic examination, chest; 2 views |
227 |
210 |
$311.38 |
| 84443 |
Thyroid stimulating hormone (TSH) |
135 |
128 |
$304.89 |
| 85610 |
|
253 |
150 |
$231.17 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29 |
27 |
$214.09 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
13 |
$110.89 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
413 |
368 |
$104.60 |
| 85027 |
|
324 |
238 |
$99.58 |
| 84484 |
|
153 |
118 |
$88.83 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
97 |
94 |
$40.04 |
| Q3014 |
Telehealth originating site facility fee |
35 |
34 |
$33.92 |
| 83690 |
|
75 |
69 |
$30.00 |
| 81001 |
|
211 |
195 |
$28.32 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
44 |
42 |
$27.42 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
13 |
$25.40 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
547 |
483 |
$22.45 |
| 83735 |
|
15 |
14 |
$7.25 |
| 36415 |
Collection of venous blood by venipuncture |
1,460 |
1,040 |
$7.00 |
| 82962 |
|
44 |
31 |
$6.00 |
| 80061 |
Lipid panel |
114 |
111 |
$2.19 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
135 |
128 |
$0.00 |
| 70450 |
Computed tomography, head or brain; without contrast material |
31 |
27 |
$0.00 |